← Back to Search

Antiseptic

1 for Catheterization

Phase 4
Waitlist Available
Led By Erik S. Thingvoll, MD
Research Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of catheter removal
Awards & highlights

Study Summary

The purpose of this study is to prevent catheter-related infections in newborn infants admitted to the Neonatal Intensive Care Unit (NICU). This study will compare the effectiveness of daily chlorhexidine versus isopropyl alcohol in preventing the growth of microbes in catheters.

Eligible Conditions
  • Catheterization

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the time of catheter removal
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the time of catheter removal for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Catheter tip microbial colonization
Secondary outcome measures
Route of catheter tip microbial colonization determined by cultures taken at the catheter hub versus skin
Time to hub microbial colonization

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Chlorhexidien as the antibacterial agent used to cleanse the hub of neonatal central lines
Group II: 2Active Control1 Intervention
Isopropyl alcohol as the antibacterial agent used to cleanse the hub of neonatal central lines

Find a Location

Who is running the clinical trial?

National Institute of Allergy and Infectious Diseases (NIAID)Lead Sponsor
3,269 Previous Clinical Trials
5,481,319 Total Patients Enrolled
University of RochesterOTHER
838 Previous Clinical Trials
518,417 Total Patients Enrolled
Erik S. Thingvoll, MDPrincipal InvestigatorUniversity of Rochester

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants
2007. "Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00516360.
All > Rsv
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top